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Abstract
The level of uptake and retention of amino-containing drugs in large unilamellar vesicles (LUVs) following uptake in
response to a transmembrane pH gradient (vpH) can vary dramatically depending on the drug. For example, the anticancer
drugs doxorubicin and epirubicin can be readily retained, whereas the anticancer drug vincristine and the antibiotic
ciprofloxacin tend to leak out rapidly. In this investigation, we examine the influence of the hydrophobicity of the entrapped
amines (that induce the vpH) and the anionic lipid content of the LUV on drug retention. It is shown that entrapment of
increasingly hydrophobic monoamines (methylamine to amylamine) all lead to an induced vpH of 3 units and essentially
complete drug uptake under the conditions employed, but do not lead to improved retention of vincristine and ciprofloxacin.
However, significantly improved retention could be achieved by substitution of the anionic lipid distearoylphos-
phatidylglycerol (DSPG) for distearoylphosphatidylcholine (DSPC) in the LUV bilayer. Further, it is shown that if the
induced vpH is reduced to 1.4 units (driven by entrapped diamine) nearly 100% accumulation of doxorubicin and epirubicin
could be achieved, whereas only 25% loading for vincristine and ciprofloxacin was observed. Taken together these results
provide methodology for improving (weak base) drug retention in liposomes and indicate that drugs that can partition into
the lipid bilayer exhibit improved uptake and retention characteristics. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Liposomal formulations of anticancer drugs, such
as doxorubicin or vincristine, and antibiotics, such as
cipro£oxacin, can result in improved therapeutic ac-
tivity and reduced toxic side e¡ects [1]. However,
these drugs can exhibit signi¢cantly di¡erent uptake
and retention properties in the large unilamellar
vesicles (LUVs) usually employed for drug delivery.
For example, both doxorubicin and vincristine can
be readily accumulated into LUVs exhibiting a pH
gradient [2,3], but vincristine leaks out much more
rapidly than doxorubicin for LUVs with the same
lipid composition [3]. Alternatively, cipro£oxacin
can be accumulated in response to a pH gradient
induced by entrapped ammonium sulfate [4] when
the exterior pH is approximately 6, but leaks from
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these LUVs relatively quickly [5]. It is clearly impor-
tant to be able to control the rate of leakage of drugs
from LUV delivery systems, as LUVs which do not
retain their contents in vivo cannot deliver them to
target sites. As a result, the e⁄cacy of liposomal
formulations is highly sensitive to drug leakage rates.
In the case of vincristine, for example, improved
drug retention in LUVs dramatically improves anti-
tumor activity [3].
In this work, we investigate two methods of regu-
lating drug release from LUVs following uptake in
response to vpH. The ¢rst involves the use of sulfate
salts of alkyl amines in place of ammonium sulfate.
The increased hydrophobicity of amines with longer
alkyl chains may be hypothesized to result in higher
levels of encapsulated amine and increased partition-
ing into the inner monolayer of the LUVs, resulting
in an increased positive surface charge and improved
retention of the positively charged drug. The second
approach is based on a model of drug uptake in
response to a pH gradient which suggests that in-
creased partitioning of drugs in the inner monolayer
is correlated with high levels of entrapped drug and
improved retention properties [2,6]. Membranes
composed of negatively charged lipids exhibit higher
membrane^water partition coe⁄cients for positively
charged drugs, which should lead to improved reten-
tion properties according to this model.
It is shown that drug retention in LUVs containing
alkylammonium sulfates of increasing hydrophobic-
ity is not improved over LUVs containing ammo-
nium sulfate. However, improved retention is ob-
served in LUVs containing the negatively charged
lipid phosphatidyl glycerol (PG). These results sup-
port the model suggesting higher membrane^water
partition coe⁄cients lead to improved drug uptake
and retention properties.
2. Materials and methods
2.1. Preparation of LUVs
Distearoyl phosphatidylcholine (DSPC), dipalmi-
toyl PC (DPPC), palmitoyl-oleoyl PC (POPC) and
egg sphingomyelin (SM) were purchased from Avanti
Polar Lipids (Alabama, USA), and were greater than
99% pure. Distearoyl PG (DSPG) was purchased
from Northern Lipids (Vancouver, Canada). Choles-
terol and the alkylamines were obtained from Sigma
(St. Louis, MO, USA). For PC/cholesterol vesicles
the acyl chain composition of the LUVs had no ma-
jor in£uence on drug uptake. The same results were
obtained for all PC/cholesterol mixtures (DSPC/
Chol, DPPC/cholesterol and POPC/Chol) and for
SM/cholesterol with a molar ratio of 55:45. For
the experimental data shown DSPC/cholesterol
(55:45 mol/mol) vesicles were used. For improved
retention of vincristine and cipro£oxacin the vesicle
composition was DSPC/DSPG/cholesterol (40:15:45)
or DSPG/cholesterol (55:45 mol/mol). DSPC/choles-
terol and SM/cholesterol lipid mixtures were pre-
pared by lyophilization from t-butanol, DSPC/
DSPG/cholesterol was lyophilized from benzene/
methanol (95:5 v/v) and DSPG/cholesterol was dried
from chloroform at a total lipid concentration of 50
mg/ml. The lipid was labeled either with
[14C]cholesteryl hexadecyl ether or [3H]cholesteryl
hexadecyl ether. [14C]Cholesteryl hexadecyl ether
was custom synthesized by DuPont New England
Nuclear (Boston, MA) and [3H]cholesteryl hexadecyl
ether was also purchased from DuPont New England
Nuclear.
Multilamellar vesicles (MLVs) were formed by hy-
dration of the lipid with a 300 mM aqueous solution
of the alkylammonium sulfate salts followed by ¢ve
freeze^thaw cycles. These MLVs were extruded 10
times [7] through an extrusion device obtained from
Lipex Biomembranes (Vancouver, BC, Canada), ¢t-
ted with two stacked Nuclepore polycarbonate ¢lters
with a pore size of 100 nm. The extruder was equi-
librated to 60‡C. The mean diameter of the vesicles
was measured with dynamic light scattering (Nic-
omp, Particle Sizing Systems, Santa Barbara, CA)
and found to be 115 þ 20 nm.
2.2. Synthesis of amino compounds and formation of
the gradient
Alkylammonium sulfate salts were synthesized by
the addition of sulfuric acid to an aqueous solution
of the appropriate amine under cooling and vigorous
stirring until the pH of the solution was neutral. The
molar ratio of amine to sulfuric acid was 2:1 except
for ethylenediammonium sulfate where it was 1:1.
About 95% of the water was then removed using a
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Brinkmann Rotavapor-R rotary evaporator at 50^
60‡C. The remaining water was removed azeotropi-
cally with absolute ethanol (¢ve to six additions) on
the rotovap, giving a wet salt precipitate. The salt
was washed with anhydrous ethylether and the sol-
vent was removed by ¢ltration through a Buchner
funnel. Residual solvent was removed under high
vacuum overnight. Sulfate salts were identi¢ed by
13C-NMR by comparison to the alkylammonium
chloride salts. The latter were purchased from Sigma.
Ammonium methylsulfate was prepared according to
Werner [8].
An amine gradient was generated by exchanging
the extravesicular solution with 150 mM NaCl, pH
7.4 or a 2-(N-morpholino)ethanesulfonic acid (MES)/
NaCl bu¡er, 20/140 mM, pH 6.0 on Sephadex G-50
spin columns [9]. To show that this procedure re-
moved the external amine quantitatively the external
solution was £uorimetrically assayed for amine after
the reaction with £uorescamine [10]. Gradients
formed using packed columns of Sephadex G-50
(1.5U10 cm) gave similar results. In order to match
physiological conditions, the extravesicular medium
was about 300 mosmol/kg. The inside and the out-
side of the LUVs were therefore not osmotically bal-
anced. Reduction of the amine concentration to 150
mM for monoamines instead of 300 mM and 300
mM EDAS instead of 600 mM had no major in£u-
ence on the results.
Table 1 gives the names, abbreviations and the
chemical formulas of all amines used. pK values
are given [11]. The pH and the osmolarity of the
300 mM aqueous solutions were measured at least
three times and the mean values are given.
2.3. pH gradient and drug uptake
The pH gradient was determined using [14C]-
methylamine and was performed as previously de-
scribed [12].
Drugs were added to the liposome preparation
(5 mM total lipid) to give a molar drug-to-lipid ratio
of 0.2 for doxorubicin, epirubicin and cipro£oxacin
and 0.03 for vincristine. The samples were incubated
at 60‡C. Aliquots were taken for determination of
drug uptake at di¡erent time points. Unentrapped
drug was removed by running the aliquots over
Sephadex G-50 spin columns prior to detection of
the liposomally entrapped drug. Doxorubicin and
epirubicin concentrations were determined by meas-
uring the absorption at 480 nm in a 1% Triton X-100
solution. Vincristine concentration was determined
either from the absorption at 297 nm in 80% ethanol
or from dual label scintillation counting using
[3H]vincristine. Cipro£oxacin concentrations were
determined by dual label scintillation counting using
[14C]cipro£oxacin or, in some cases, from absorption
readings at 273.5 nm after a Bligh^Dyer extraction
[13] into 200 mM NaOH as aqueous phase. The re-
sults from UV spectrometry and radiolabel analysis
were in very good agreement. The lipid concentration
was determined from scintillation counting and phos-
phate assays.
Doxorubicin (adriamycin RDF), epirubicin (phar-
morubicin RDF) and vincristine sulfate (vincasar
PFS) were obtained from Pharmacia (Mississauga,
Ont., Canada) and [3H]vincristine sulfate was ob-
tained from Amersham (Oakville, Ont., Canada). Ci-
pro£oxacin and [14C]cipro£oxacin were from Bayer
Table 1
Amine compounds encapsulated in liposomes
Name Abbreviation Formula pK pHa Osmolaritya
Ammonium sulfate AS (NH4)2SO4 9.2 5.1 622
Methylammonium sulfate MAS (CH3NH3)2SO4 10.7 4.1 663
Ethylammonium sulfate EAS (CH3CH2NH3)2SO4 10.8 4.2 717
Diethylammonium sulfate DEAS ((CH3CH2)2NH2)2SO4 11.2 5.0 748
Propylammonium sulfate PAS (CH3CH2CH2NH3)2SO4 10.8 5.1 666
Amylammonium sulfate AAS (CH3(CH2)4NH3)2SO4 10.6 6.2 752
Ethylenediammonium sulfate EDAS [H3NCH2CH2NH3]SO4 7.4, 10.2 5.1 360
Ammonium methyl sulfate AMS NH4CH3OSO3 ^ 5.4 536
apH and osmolarity are given for 300 mM aqueous solutions of the respective sulfate salt.
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(Leverkusen, Germany). Fig. 1 shows the chemical
structures of epirubicin and doxorubicin, cipro£oxa-
cin and vincristine and their pK values. Doxorubicin
di¡ers from epirubicin only in the stereochemistry of
the OH bearing C-4 on the amino sugar. The pK of
doxorubicin is 8.6. Regarding the zwitterionic prop-
erty of cipro£oxacin it is important to note that as
the pK of the carboxyl function is rather high
(pK1 = 6.0) and the intraliposomal pH is very low
the carboxyl groups are almost completely proto-
nated. Thus the entrapped cipro£oxacin can be re-
garded as a weak base drug.
2.4. In vitro assay for drug retention
In vitro release experiments were carried out in test
tubes by diluting samples after maximal drug uptake
1:1 (v/v) with normal mouse serum (Cedar Lane
Laboratories, Hornby, Ont., Canada) followed by
incubation at 37‡C. Samples at various time points
were taken and concentrations of entrapped drugs
were determined as described for drug uptake experi-
ments. For these experiments, the ratio of concentra-
tions of mouse serum and total lipid is important
[14]. A ratio of 1:10 (v/v) of mouse serum to sample
liberated only 40% of encapsulated cipro£oxacin
within 15 min compared to 90^95% with 1:1 mouse
serum.
3. Results
3.1. Drug accumulation in response to monoamine
sulfate gradients
It has previously been shown that when ammo-
nium sulfate is entrapped within LUVs and exterior
ammonium sulfate is removed, a transmembrane
vpH is established that can drive the accumulation
of drugs which are weak bases [4]. The vpH is set up
due to the e¥ux of neutral ammonia molecules, each
of which leaves a proton behind in the LUV interior,
leading to a proton gradient according to the relation
Hin=Hout  NH4  in=NH4 out. The mechanism
of loading of drugs in response to a pH gradient is
depicted in Fig. 2. In the present study, we hypothe-
sized that sulfate salts of more hydrophobic amino
compounds may lead to improved uptake and reten-
tion of weak base drugs. An increase in partitioning
of the alkylamine into the inner monolayer of the
LUVs may be expected to lead to higher levels of
entrapped amino sulfate and the establishment of a
positive surface charge at the inner monolayer inter-
face, which may, in turn, inhibit e¥ux of the posi-
tively charged entrapped drug. In order to establish
Fig. 1. Chemical structures of (A) epirubicin and doxorubicin
(details circumscribed), (B) cipro£oxacin and (C) vincristine and
their pK values. Doxorubicin and epirubicin have the same
structure, but di¡er in their stereochemistry of the OH bearing
C-4 of the sugar moiety. This has a strong in£uence on the pK
value being increased for doxorubicin to pK = 8.6.
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that alkylamines with increased alkyl chain length
show higher membrane^water partitioning, the £uo-
rescence of the surface potential probe TNS was
measured in the presence of amylammonium sulfate
and methylammonium sulfate. 2-(p-Toluidino)naph-
thalene-6-sulfonic acid (TNS) £uorescence increased
in the presence of amylammonium sulfate, but not
methylammonium, consistent with a higher mem-
brane^water partition coe⁄cient for the more hydro-
phobic compound (results not shown).
A variety of alkylammonium sulfates were synthe-
sized (see Table 1) and entrapped (300 mM) in DSPC/
cholesterol (55/45 mol/mol) LUVs (100 nm diame-
ter). After exchange of exterior alkylammonium sul-
fate for 150 mM NaCl pH 7.4 and incubation at
60‡C for 15 min, a vpH of approximately 3 units
was established, as shown in Fig. 3A. This vpH
was the same for all alkylammonium sulfate salts
employed, as assayed by the transbilayer distribution
of trace levels of radiolabeled methylamine. This val-
ue of vpH corresponds well with the value expected
on the basis of the transbilayer distribution of the
alkylamine. In the case of entrapped methylammo-
nium sulfate, for example, the methylamine concen-
tration outside the LUVs after establishing the vpH
was found to be 0.8 þ 0.05 mM and the internal
methylamine concentration was 457 þ 50 mM, corre-
sponding to a vpH of about 2.8 units. It should be
noted that whereas other investigators [15] have
found it necessary to reduce the pH of the ammo-
nium sulfate solution to pH 2.5 in order to achieve
good uptake of cipro£oxacin, no such adjustment in
pH of the monoamines employed here was required.
Drug uptake also correlates well with the amount
Fig. 2. Diagram of the mechanism for remote loading of drugs into LUVs comprising a vpH. (A) 100 nm LUVs were obtained by
hydration of the dry lipid in 300 mM aqueous amine (b) solution and subsequent extrusion. (B) After exchange of the external amine
with 150 mM NaCl or MES/NaCl bu¡er on a Sephadex G-50 spin column the amine equilibrates leading to a vpH (inside acidic) as
the neutral form (black oval) crosses the bilayer. (C) The neutral form of the externally added drug (small gray rectangle) can cross
the bilayer and is protonated (larger gray rectangle) and trapped inside the vesicles. Monobasic drugs exchange 1:1 with the amine
while the ratio of amine/vincristine is 2:1.
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of amine crossing the membrane in exchange for the
drug. A previous report suggests an exchange ratio
of 1:4 for doxorubicin and NH4 , concluding that
loading was much lower than the loading capacity
[4]. However, for a methylammonium sulfate gra-
dient we found a 1:1 exchange of methylamine and
drug for the monobasic drugs doxorubicin, epirubi-
cin and cipro£oxacin while the ratio of vincristine
in£ux to methylamine e¥ux was found to be about
1:2, consistent with the two basic groups of vincris-
tine (data not shown). Thus e¥ux of entrapped
amine is tightly coupled with drug in£ux.
The next set of experiments was aimed at deter-
mining the uptake and retention properties of dox-
orubicin, epirubicin, vincristine and cipro£oxacin for
LUVs containing these alkylamines after establishing
the pH gradient. As shown in Fig. 3B, all of these
drugs exhibit 80% or higher loading levels after 5 min
incubation (at 60‡C) with DSPC/cholesterol LUVs
(containing 300 mM ethylammonium sulfate) in the
presence of drug at a drug to lipid ratio of 0.2 (mol/
mol) for doxorubicin, epirubicin and cipro£oxacin
and 0.03 (mol/mol) for vincristine. This behavior
was found to be representative for all the alkyl-
amines employed as very similar levels of drug up-
take were observed for all other species.
The retention properties of doxorubicin, epirubi-
cin, cipro£oxacin and vincristine following uptake
into DSPC/cholesterol LUVs were also found to be
independent of the type of alkylammonium sulfate
used (results not shown). Retention was, however,
highly dependent on the particular drug employed.
As shown in Fig. 4, after uptake in response to en-
trapped methylammonium sulfate and gradient for-
mation with 150 mM NaCl pH 7.4, on incubation at
37‡C in the presence of 50% mouse serum, essentially
all accumulated cipro£oxacin is released within 5 min
Fig. 3. (A) Formation of transmembrane pH gradient in 100
nm DSPC/cholesterol vesicles at 60‡C subsequent to exchange
of the external solution with 150 mM NaCl pH 7.4 and equili-
bration of the encapsulated amino compound, i.e. AS (b),
MAS (F), EAS (O), DEAS (R), PAS (S), AAS (8) and
AMS (a). The equilibrium is reached when the inside and out-
side concentrations of the neutral form of the amino compound
are equal, giving a vpH of 3 units as measured employing ex-
ternally added [14C]methylamine. (B) Comparison of the extent
of drug uptake using encapsulated EAS. Experiments were con-
ducted using 100 nm DSPC/cholesterol LUVs (55:45 mol/mol)
at a total lipid concentration of 5 mM and drug-to-lipid ratios
of 0.2 (mol/mol) for doxorubicin (b), epirubicin (F) and cipro-
£oxacin (R) and 0.03 (mol/mol) for vincristine (S).
Fig. 4. Release of doxorubicin (b), epirubicin (F), cipro£oxacin
(R) and vincristine (S) from 100 nm DSPC/cholesterol (55:45
mol/mol) vesicles (5 mM total lipid concentration) following
loading under the conditions indicated in the legend to Fig. 3.
Release was measured in the presence of 50% normal mouse se-
rum at an incubation temperature of 37‡C.
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and only 25% vincristine remains encapsulated after
1 h. This behavior contrasts strongly with the reten-
tion properties of doxorubicin and epirubicin, which
exhibit little or no leakage over the 1-h incubation
time.
3.2. Drug accumulation in response to diamine sulfate
gradients
It has been shown previously that more doxorubi-
cin is accumulated into LUVs exhibiting a vpH than
would be expected on the basis of the pH gradient
alone [2]. This has been attributed to partitioning of
accumulated doxorubicin into the inner monolayer,
which would give rise to doxorubicin concentration
gradients which are larger than the proton concen-
tration gradients according to the equation:
Doxorubicini
Doxorubicino  1 Kp
Vm
V i
H
i
Ho 1
where Kp is the membrane^water partition coe⁄cient
of the drug, Vm is the volume of the LUV membrane
and Vi is the volume of the aqueous interior. For a
100-nm-diameter LUV, Vm/ViV0.33 and thus for a
membrane^water partition coe⁄cient of V70, as has
been determined for doxorubicin [2], the concentra-
tion gradient of doxorubicin across the LUV mem-
brane is approximately 20 times higher than would
be predicted from the proton gradient. It is of inter-
est to determine whether similar e¡ects are observed
for poorly retained drugs such as vincristine and ci-
pro£oxacin so that their reduced membrane^water
partition coe⁄cients are related to the shorter reten-
tion times.
Accumulation in response to the entrapped mono-
amines, which give rise to an initial vpH of 3 units,
results in nearly complete encapsulation of all the
drugs employed under the conditions used here. At
some smaller vpH it would be expected from Eq. 1,
that drugs exhibiting large membrane^water parti-
tion coe⁄cients should show improved uptake over
those with smaller partition coe⁄cients. In this re-
gard, assuming the neutral form is membrane perme-
able, it is straightforward to show that the proton
gradient resulting from an entrapped diamine will
obey the relationship [H]in/[H]out = ([diamine]in/[di-
amine]out)1=2, and thus the vpH induced should be
half that observed for the monoamines. As shown in
Fig. 5A, the vpH induced in response to entrapped
ethylenediammonium sulfate is 1.4 units, in good
agreement with this prediction.
The accumulation of doxorubicin, epirubicin, ci-
pro£oxacin and vincristine in response to this re-
duced vpH is illustrated in Fig. 5B. It may be ob-
served that whereas more than 80% of available
doxorubicin and epirubicin are accumulated over
the 30 min incubation period, less than 25% of the
cipro£oxacin and vincristine is sequestered. This be-
havior is consistent with reduced membrane^water
partition coe⁄cients for cipro£oxacin and vincristine
as compared to doxorubicin and epirubicin.
Fig. 5. (A) Formation of a transmembrane pH gradient in 100
nm DSPC/cholesterol (55:45 mol/mol) vesicles following entrap-
ment of the diamine, EDAS. (B) Comparative uptake of doxor-
ubicin (b), epirubicin (F), cipro£oxacin (R) and vincristine (S)
into 100 nm DSPC/cholesterol (55:45 mol/mol) LUVs using 300
mM EDAS at 60‡C for 30 min. More than 80% doxorubicin
and epirubicin are accumulated in response to a pH gradient of
1.4 units, while less than 25% cipro£oxacin and vincristine is
taken up.
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3.3. Drug accumulation and retention in LUVs
containing anionic lipids
It is well known that the membrane^water parti-
tion coe⁄cients of charged molecules are highly sen-
sitive to the charge on the membrane [16]. It would
be expected, for example, that the use of negatively
charged lipids in the LUVs experiencing a vpH
would increase the membrane^water partition coe⁄-
cients of the positively charged drugs employed here.
In turn, according to Eq. 1, it would be expected that
these drugs should exhibit improved retention prop-
erties in LUVs containing anionic lipids. In order to
test this possibility, the retention properties of cipro-
£oxacin and vincristine were examined in LUVs
containing varying amounts of the negatively
charged phospholipid, distearoylphosphatidylglyc-
erol (DSPG). Using a methylammonium sulfate gra-
dient (external methylammonium sulfate was ex-
changed with MES/NaCl bu¡er at pH 6.0),
essentially complete uptake of all drugs was reached
after 15 min of incubation at 60‡C.
As shown in Fig. 6A, the half-times for retention
of cipro£oxacin in the presence of serum are in-
creased from less than 10 min for DSPC/cholesterol
(55:45 mol/mol) LUVs to approximately 30 min for
DSPG/cholesterol (55:45 mol/mol) LUVs. Alterna-
tively, for vincristine (Fig. 6B), the inclusion of as
little as 15 mol% DSPG in the DSPC/cholesterol
LUVs increases the retention half-times from 1 h to
approximately 2 h, and considerably better retention
is observed for the DSPG/cholesterol LUVs. The pH
of the external serum solution rose to 8.2 during the
course of this experiment. It should be noted that the
improved drug retention for vincristine and cipro-
£oxacin with PG-containing vesicles compared to
PC-containing vesicles was more pronounced at this
higher external pH. Although a signi¢cantly higher
amount of amine is associated with PG vesicles,
about 30% more than with PC vesicles, control ex-
periments showed that this does not in£uence reten-
tion. Uptake and retention of doxorubicin and epi-
rubicin in PG containing vesicles was similar to that
observed for neutral PC vesicles. Both drugs were
readily taken up and did not leak out of vesicles
diluted with mouse serum (1:1) during a 1-h incuba-
tion (data not shown).
4. Discussion
This study was performed to identify parameters
which lead to enhanced retention of amino contain-
ing drugs in LUV systems exhibiting a transmem-
brane pH gradient (interior acidic). The results pre-
Fig. 6. Release of (A) cipro£oxacin and (B) vincristine from
100 nm DSPG/cholesterol (55:45 mol/mol) (b), DSPC/DSPG/
cholesterol (40:15:45 mol/mol) (F) and DSPC/Cholesterol
(55:45 mol/mol) (R) vesicles (5 mM total lipid concentration).
After exchange of the external MAS (300 mM) for MES/NaCl
(20/150 mM, pH 6.0) a vpH of 3 units was driving uptake of
cipro£oxacin (drug/lipid = 0.2 mol/mol) or vincristine (drug/lip-
id = 0.03 mol/mol). After 15 min of incubation at 60‡C, uptake
was essentially complete with close to 100% of the drug loaded.
Release of cipro£oxacin and vincristine was measured in the
presence of 50% normal mouse serum at 37‡C following load-
ing. Retention is signi¢cantly improved with PG-containing
vesicles compared to PC-containing vesicles. Final pHo after 2 h
was 8.2.
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sented indicate that factors that lead to enhanced
drug partitioning into the LUV lipid bilayer improve
retention properties. The observations that support
this conclusion include the lack of improvement in
retention for uptake in response to entrapped hydro-
phobic alkylamines, the much higher uptake of dox-
orubicin and epirubicin versus cipro£oxacin and vin-
cristine for LUVs containing diammonium sulfate
and the improved retention of cipro£oxacin and vin-
cristine in LUVs comprised, at least in part, of the
negatively charged phospholipid, phosphatidylglycer-
ol. Finally, the results presented here provide poten-
tial methods to improve drug retention and potency
in vivo. We discuss these aspects in turn.
The fact that increased hydrophobicity of en-
trapped amino compounds does not a¡ect the uptake
and retention of the drugs employed here suggests
that a positive surface charge on the inner mono-
layer^water interface does not in£uence the uptake
and release of entrapped positively charged drug.
The largest e¡ects would be expected for entrapped
amylammonium sulfate, where the hydrophobic pen-
tyl chain should lead to the largest partitioning ef-
fects and the largest inner monolayer surface charge;
however, retention of cipro£oxacin and vincristine
on incubation with 50% mouse serum was not im-
proved.
The uptake properties of doxorubicin and epirubi-
cin versus vincristine and cipro£oxacin in response to
the reduced vpH of 1.5 units achieved in response to
entrapped diammonium sulfate are of particular in-
terest. As indicated by Eq. 1, the ability of a drug to
partition into the inner monolayer after uptake is
expected to lead to equilibrium transmembrane con-
centrations of drug which exceed the transmembrane
concentration of protons by the ratio 1+KpVm/Vi,
where Kp is the membrane^water partition coe⁄-
cient. For drugs such as doxorubicin, for which
KpV70 [2], this has the e¡ect of causing much higher
drug accumulation into LUVs than would be ex-
pected on the basis of the vpH. For example, for a
drug with Kp = 0, the equilibrium transbilayer drug
concentration gradient is 32 for a vpH of 1.5 units,
whereas if Kp = 70 the equilibrium concentration gra-
dient is about 760. Under the conditions employed
for the results shown in Fig. 5 the expected encapsu-
lation e⁄ciency resulting from a vpH of 1.5 units
would be 85% for Kp = 70 and only 19% for Kp = 0.
As a result, the much larger accumulation of doxo-
rubicin and epirubicin as compared to vincristine and
cipro£oxacin for vpH = 1.5 (Fig. 4B) could be di-
rectly related to di¡erences in the membrane^water
partition coe⁄cients of these drugs.
The improvement in retention for vincristine and
cipro£oxacin entrapped in LUVs containing phos-
phatidylglycerol is also clearly consistent with the
partitioning model. It should be noted that in the
absence of membrane partitioning e¡ects the pres-
ence of PG would be expected to increase, rather
than decrease, membrane permeability. This is be-
cause negatively charged lipids generally give rise to
more permeable bilayers than phosphatidylcholine
bilayers with the same acyl chain composition [17]
and also give rise to signi¢cantly higher binding of
serum proteins [18], which strongly promote leakage.
It could be argued that the drugs with higher pK
values should exhibit superior retention. Higher pK
values will lead to lower concentrations of the depro-
tonated, membrane permeable, form of the drug.
However, the rates of leakage do not correlate with
the pK values of the drugs employed here. The pK
values of the amino functions are 7.4 for vincristine,
7.7 for epirubicin, 8.6 for doxorubicin and 8.8 for
cipro£oxacin (Fig. 1). Epirubicin and vincristine on
the one hand and doxorubicin and cipro£oxacin on
the other hand have very similar pK values. Their
retention properties are, however, very di¡erent.
While epirubicin and doxorubicin are readily re-
tained, vincristine and cipro£oxacin leak out rapidly.
This indicates that the di¡erent retention properties
of the drugs are not related to their pK values.
The results presented here are also relevant to the
di⁄culty in discerning between membrane partition-
ing and precipitation of accumulated drug in the
LUV interior as the cause of drug encapsulation lev-
els which exceed values expected on the basis of
transmembrane pH gradients. As pointed out else-
where, if all of the accumulated drug is in the aque-
ous interior the concentration of drug can exceed the
solubility of the drug by orders of magnitude, poten-
tially leading to drug precipitation in the vesicle in-
terior [2,4,6]. This would have similar e¡ects as drug
partitioning into the membrane, as more drug would
be present in the vesicle interior than would be ex-
pected on the basis of the vpH. The observation that
improved retention is observed for the PG-contain-
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ing LUVs is consistent with the partitioning model,
and o¡ers an interesting direction to pursue to re-
solve this area of contention.
A ¢nal point is that the results presented here
demonstrating improved drug retention in vitro for
vesicles containing negatively charged lipids, such as
PG, o¡er a potential method for improving drug
retention in vivo, which, for drugs such as vincris-
tine, can result in signi¢cant improvements in e⁄-
cacy. For example, methods resulting in improved
retention of vincristine in liposomes in vitro resulted
in improved retention in vivo [3] and dramatically
enhanced e⁄cacy in a murine P388 lymphocytic leu-
kemia model [19]. Future studies will address the
possibility that inclusion of negatively charged lipids
in liposomes containing vincristine can o¡er similar
bene¢ts.
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